ANGUS Chemical Company, a global manufacturer and marketer of specialty ingredients for biotechnology, pharmaceutical, consumer and industrial applications, has announced the appointment of Julie O’Neill to the Company’s Board of Directors.
“Julie is an inspirational leader with an exceptional track record of successfully driving growth and profitability in leading life sciences companies while building key partnerships with regulatory, customer and employee stakeholders,” said David Neuberger, ANGUS President and Chief Executive Officer. “We are thrilled to welcome Julie to our board. I believe her passion and expertise in business management, manufacturing, regulatory and quality management will be invaluable as we extend ANGUS’ position as a leading global supplier of essential life sciences ingredients.”
“I am delighted to join the Board of Directors of ANGUS,” said O’Neill. “I look forward to contributing to the Company’s future growth and to working alongside management and the board to advance our strategy.”
O’Neill most recently served as Executive Vice President of Global Operations for Alexion Pharmaceuticals, Inc., with direct leadership responsibility for the company’s process development, product development, manufacturing quality, supply chain, customer operations, and global real estate functions encompassing approximately 1,000 employees.
Currently, O’Neill serves as a board member for Achilles Therapeutics Limited, ILC Dover LP, ICON plc, HOOKIPA Pharma and DBV Technologies. She also serves as board member and Audit and Risk Committee Chair for the National Institute for Bioprocessing Research and Training (NIBRT) in Ireland. She received her master’s degree in business administration from University College Dublin and her bachelor’s degree in pharmacy from Trinity College Dublin.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.